glp-1 kidney outcomes news receptor agonists' impact on cardio-renal and mortality in T2D with acute disease Glucagon‐Like Peptide‐1 Receptor Agonist Use

L-Carnitine Fumarate suitable to transport adipose acids inside the mitochondria to share in the beta- oxidation process, which promotes adipose acid metabolism and allows the body to use fat more efficiently as an energy source

It could potentially help with various age and metabolic-related diseases for this reason (7)

These effects are real but work at a systemic level rather than targeting specific injury sites

Their findings were striking: AKD patients treated with GLP-1 RAs experienced lower rates of major adverse kidney events (MAKEs), which include complications like the need for dialysis, worsening kidney function, and even death due to kidney failure